- PZU reported a net income of 1.76 billion zloty in the first quarter of 2025.
- This net income marks a 40% increase compared to the same period last year.
- The net income surpassed the estimate of 1.52 billion zloty.
- Insurance sales reached 7.53 billion zloty, reflecting a 7.4% growth year-over-year.
- Sales were slightly below the estimated 7.57 billion zloty.
- PZU’s operating profit totaled 4.46 billion zloty, an 18% increase from the previous year.
- Market analysts show confidence with 7 buy ratings, 3 hold ratings, and no sell ratings for PZU shares.
A look at Powszechny Zaklad Ubezpieczen Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 5 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 4.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Powszechny Zaklad Ubezpieczen SA, a company specializing in property and casualty insurance, is showing a promising long-term outlook as per the Smartkarma Smart Scores. With a high score in Dividend and Momentum, the company appears well-positioned to provide consistent returns to its investors. The strong emphasis on growth and the solid performance in resilience further underpin the company’s stability and potential for expansion in the insurance market.
Powszechny Zaklad Ubezpieczen‘s strategic focus on value, coupled with its sound dividend policy and robust growth prospects, signal a positive trajectory for the company. The high momentum score reflects the company’s ability to capitalize on market opportunities and drive performance. With a diverse portfolio of non-life insurance products, including fire and automobile insurance, as well as a life insurance division, Powszechny Zaklad Ubezpieczen is well-positioned to navigate challenges and capitalize on growth opportunities in the insurance sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
